Rallybio Corp (RLYB) · Oct 26, 2026 · Other events

Rallybio cash distribution set ahead of Avenzo merger closing

$82.7M cash distribution — Estimated $13.56 per share, payable after merger approval

Rallybio’s new filing locks in an estimated $13.56-per-share cash distribution, with the Avenzo merger and shareholder vote still the gating events.

Rallybio is transitioning from a rare-disease biotech into the Avenzo-led oncology company through a reverse merger, backed by a planned $215 million financing and a pipeline of clinical-stage cancer programs. This filing mainly formalizes the cash-out mechanics, rather than changing that strategic story. The board declared an estimated $82.7 million special cash distribution, or $13.56 per share, funded by Rallybio’s pre-closing net cash.

ItemFiling detail
Estimated total cash distribution$82.7 million (Cash Distribution)
Estimated distribution per share$13.56 (Cash Distribution)
Record dateNovember 5, 2026, subject to change (Cash Distribution)
Expected payment dateNovember 13, 2026 (Cash Distribution)
Expected merger closingOn or about November 6, 2026 (Cash Distribution)

The amount is broadly consistent with what was already known. Earlier merger materials had estimated Rallybio’s net cash at approximately $82.2 million and contemplated distributing substantially all of it before or around closing, so the new information is the precise estimate, record-date mechanics, and due-bill treatment—not a surprise change in value.

The real remaining risk is execution, not the distribution decision. Payment is conditioned on the required stockholder vote scheduled for November 4, 2026, while the merger is targeted for November 6, 2026; the filing also fixes the same record date for the previously announced contingent value rights. 〔0〕 〔1〕

Bottom line: This is a confirmation and implementation notice for the already expected pre-merger cash return. It matters for timing and settlement, but does not materially alter Rallybio’s broader transition into Avenzo or remove the shareholder-approval condition.ka

What to watch next

Stockholder vote November 4; merger closing targeted November 6

Original filing on SEC EDGAR

More Rallybio Corp news

Rallybio cash distribution set ahead of Avenzo merger closing | RLYB Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.